Charles Schwab’s cbdMD YCBD Stock Holding History

Charles Schwab’s Portfolio YCBD Stock Details YCBD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-40	Closed	-$16K	–	3627
2021 Q4	$16K	Hold	40	–	–	﹤0.01%	3586
2021 Q3	$30K	Hold	40	–	–	﹤0.01%	3489
2021 Q2	$42K	Hold	40	–	–	﹤0.01%	3392
2021 Q1	$60K	Buy	+40	New	+$58.1K	﹤0.01%	3422
2020 Q2	–	Sell	-193	Closed	-$65K	–	3367
2020 Q1	$65K	Buy	193 +138	+251%	+$54.4K	﹤0.01%	3138
2019 Q4	$45K	Hold	55	–	–	﹤0.01%	3131
2019 Q3	$78K	Hold	55	–	–	﹤0.01%	3108
2019 Q2	$116K	Buy	+55	New	+$112K	﹤0.01%	3123

Other funds holding YCBD

Merlin Capital Newport, Rhode Island $33.5M AUM 36.34% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $299B AUM 28.69% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AdvisorShares Investments Bethesda, Maryland $549M AUM 32.58% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

PCM

Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

CIM

Cambria Investment Management Manhattan Beach, California $1.79B AUM 28.1% 1-Year Est. Return

Charles Schwab's YCBD Position: Q1 2022 in Review

Charles Schwab sold out of cbdMD (YCBD) in Q1 2022, closing a stake of 40 shares — an estimated $16K sold.

Charles Schwab first reported a position in YCBD in Q2 2019 and held it in 8 quarters. The position peaked at $116K in Q2 2019. 49 funds tracked by Wall St. Rank hold YCBD as of Q1 2022.

Charles Schwab reported no remaining cbdMD position as of Q1 2022 after selling out during the quarter.
Charles Schwab sold 40 cbdMD shares in Q1 2022, an estimated $16K.
Charles Schwab first reported a position in cbdMD in Q2 2019 and held it in 8 quarters.
Charles Schwab's cbdMD position peaked at $116K in Q2 2019.
49 funds tracked by Wall St. Rank held cbdMD as of Q1 2022.

Based on Charles Schwab's 13F filing for Q1 2022, filed 13 May 2022.